RNAi Roundtable: Givosiran, in Development for the Treatment of Acute Hepatic Porphyria

07 Oct, 2019 RNAi Roundtable: Givosiran, in Development for the Treatment of Acute Hepatic Porphyria

On October 7, 2019, we hosted an online RNAi Roundtable to review the progress with givosiran, an RNAi therapeutic in development for the treatment of acute hepatic porphyria.

Access the replay

View the presentation

Read the transcript

• • Akin Akinc, Ph.D., General Manager, Givosiran
  • Srikanth Nagalla, M.D., M.S., Associate Professor of Internal Medicine, Medical Director of Blood Disorders Clinic, Program Director of Hematology/Oncology Fellowship, UT Southwestern Medical Center
  • Jae Kim, M.D., Vice President, Clinical Development